Analysis of chemokine and cytokine expression in patients with HIV and GB virus type C coinfection

Clinical Infectious Diseases

Volumn 40, Issue 9, 2005, Pages 1342-1349

  Giménez Barcons, Mireia ^a   Ribera, Meritxell ^a   Llano, Anuska ^a   Clotet, Bonaventura ^a   Esté, Jose A ^a   Martínez, Miguel A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE; CYTOKINE; INTERLEUKIN 7; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; STROMA; SYNCYTIUM; T LYMPHOCYTE; VIREMIA; VIRUS INFECTION; VIRUS ISOLATION;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; GENE EXPRESSION REGULATION; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIREMIA;

EID: 17644368999     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429320     Document Type: Article

References (40)

1. Linnen J, Wages J Jr., Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-8.
2. Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis 2001; 33:572-80.
3. Giménez-Barcons M, Sanchez-Tapias J, Saiz JC. Clinical implications of hepatitis G virus (HGV) infection. Clin Lab 1999; 45:631-8.
4. Puig-Basagoiti F, Cabana M, Guilera M, et al. Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J Acquir Immune Defic Syndr 2000; 23:89-94.
5. Ibanez A, Gimenez-Barcons M, Tajahuerce A, et al. Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission. J Med Virol 1998; 55:293-9.
6. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-6.
7. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-86.
8. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-24.
9. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-14.
10. Quiros-Roldan E, Maroto MC, Torti C, et al. No evidence of benefical effect of GB virus type C infection on the course of HIV infection. AIDS 2002; 16:1430-1.
11. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-infected patients. AIDS 2002; 16:2482-5.
12. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-9.
13. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004; 363:2040-6.
14. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700.
15. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
16. Trkola A, Gordon C, Matthews J, et al. The CC-chemokme RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol 1999; 73:6370-9.
17. + T cells. Science 1995; 270:1811-5.
18. Berger EA, Doms RW, Fenyo EM, et al. A new classification for HIV. Nature 1998; 391:240.
19. + cell depletion and progression to AIDS. Ann Intern Med 1993; 118:681-8.
20. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T cell-tropic virus population. J Virol 1992; 66:1354-60.
21. Fry TJ, Connick E, Falloon J, et al. A potential role for interleukin-7 in T cell homeostasis. Blood 2001; 97:2983-90.
22. Uittenbogaart CH, Boscardin WJ, Anisman-Posner DJ, Koka PS, Bristol G, Zack JA. Effect of cytokines on HIV-induced depletion of thymocytes in vivo. AIDS 2000; 14:1317-25.
23. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-mediated T cell depletion: implications for T cell homeostasis. Nat Med 2001; 7:73-9.
24. Llano A, Barretina J, Gutierrez A, et al. Interleukin-7 in plasma correlates with CD4 T cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001; 75:10319-25.
25. Llano A, Barretina J, Blanco J, Gutierrez A, Clotet B, Este JA. Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV in vivo. AIDS 2001; 15:1890-2.
26. Gimenez-Barcons M, Ibanez A, Tajahuerce A, et al. Genetic evolution of hepatitis G virus in chronically infected individual patients. J Gen Virol 1998; 79:2623-9.
27. Llano A, Barretina J, Gutierrez A, Clotet B, Este JA. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression. J Virol 2003; 77:4389-95.
28. Este JA, Cabrera C, Blanco J, et al. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J Virol 1999; 73:5577-85.
29. Tillmann HL, Manns MP. GB virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res 2001; 52:83-90.
30. Grivel JC, Ito Y, Faga G, et al. Suppression of CCR5- but not CXCR4-tropic HIV in lymphoid tissue by human herpesvirus 6. Nat Med 2001; 7:1232-5.
31. Hoshino Y, Tse DB, Rochford G, et al. Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV replication in human macrophages. J Immunol 2004; 172:6251-8.
32. DeVico AL, Gallo RC. Control of HIV infection by soluble factors of the immune response. Nat Rev Microbiol 2004; 2:401-13.
33. + mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. J Virol 2003; 77:5784-93.
34. Shalekoff S, Tiemessen CT. Circulating levels of stromal cell-derived factor 1α and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes. AIDS Res Hum Retroviruses 2003; 19:461-8.
35. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-90.
36. Pomerantz RJ, Nunnari G. HIV and GB virus C: can two viruses be better than one? N Engl J Med 2004; 350:963-5.
37. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV infection in persons with GB virus C coinfection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003; 139:26-30.
38. Holodniy M, Katzenstein DA, Sengupta S, et al. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis 1991; 163:862-6.
39. Lefrere JJ, Ferec C, Roudot-Thoraval F, et al. GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 1999; 59:32-7.
40. Nattermann J, Nischalke HD, Kupfer B, et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17:1457-62.